{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:35:00Z","timestamp":1790739300925,"version":"4.1.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"medical corps Israel Defense Forces","award":["4440985218"],"award-info":[{"award-number":["4440985218"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess type 2 diabetes risk among adolescents with NAFLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Setting<\/jats:title>\n                  <jats:p>A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997\u20132011 and were followed until December 31, 2016.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>A total of 1 025 796 normoglycemic adolescents were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Type 2 diabetes incidence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47\u20134.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa753","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T22:47:13Z","timestamp":1603147633000},"page":"e34-e44","source":"Crossref","is-referenced-by-count":27,"title":["Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood"],"prefix":"10.1210","volume":"106","author":[{"given":"Aya","family":"Bardugo","sequence":"first","affiliation":[{"name":"Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole D","family":"Bendor","sequence":"additional","affiliation":[{"name":"Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbar","family":"Zucker","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"The Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Lutski","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"The Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Cukierman-Yaffe","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Derazne","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofri","family":"Mosenzon","sequence":"additional","affiliation":[{"name":"The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Tzur","sequence":"additional","affiliation":[{"name":"Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivan","family":"Beer","sequence":"additional","affiliation":[{"name":"Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Pinhas-Hamiel","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Ben-Ami","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Fishman","sequence":"additional","affiliation":[{"name":"Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Internal Medicine D and Hypertension Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Ben-Ami Shor","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Department of Gastroenterology, Tel-Aviv Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itamar","family":"Raz","sequence":"additional","affiliation":[{"name":"The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Afek","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Central Management, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C","family":"Gerstein","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Institute of Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"German Center for Diabetes Research, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-5906","authenticated-orcid":false,"given":"Amir","family":"Tirosh","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Levi","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Gastroenterology Department, Rabin Medical Center, Petach Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2829-3645","authenticated-orcid":false,"given":"Gilad","family":"Twig","sequence":"additional","affiliation":[{"name":"Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"1","key":"2021122204214346300_CIT0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"2021122204214346300_CIT0002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"4","key":"2021122204214346300_CIT0003","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"2021122204214346300_CIT0004","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics."},{"issue":"10","key":"2021122204214346300_CIT0005","doi-asserted-by":"crossref","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One."},{"issue":"11","key":"2021122204214346300_CIT0006","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut."},{"issue":"5","key":"2021122204214346300_CIT0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/children4050034","article-title":"Natural history of NAFLD diagnosed in childhood: a single-center study","volume":"4","author":"Cioffi","year":"2017","journal-title":"Children."},{"key":"2021122204214346300_CIT0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cct.2018.11.003","article-title":"European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): design and rationale","volume":"75","author":"Mann","year":"2018","journal-title":"Contemp Clin Trials."},{"key":"2021122204214346300_CIT0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cct.2017.07.015","article-title":"Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: the TARGET-NASH study","volume":"61","author":"Barritt","year":"2017","journal-title":"Contemp Clin Trials."},{"issue":"1","key":"2021122204214346300_CIT0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc19-1562","article-title":"Childhood pancreatitis and risk for incident diabetes in adulthood","volume":"43","author":"Bendor","year":"2020","journal-title":"Diabetes Care."},{"issue":"7","key":"2021122204214346300_CIT0011","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc19-1988","article-title":"Adolescent obesity and early-onset type 2 diabetes","volume":"43","author":"Twig","year":"2020","journal-title":"Diabetes Care."},{"key":"2021122204214346300_CIT0012","author":"Bardugo"},{"issue":"11","key":"2021122204214346300_CIT0013","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.2337\/dc14-0715","article-title":"Cognitive function and the risk for diabetes among young men","volume":"37","author":"Twig","year":"2014","journal-title":"Diabetes Care."},{"issue":"4","key":"2021122204214346300_CIT0014","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med."},{"issue":"6","key":"2021122204214346300_CIT0015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"Jama."},{"issue":"3","key":"2021122204214346300_CIT0016","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics."},{"issue":"6","key":"2021122204214346300_CIT0017","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"3","key":"2021122204214346300_CIT0018","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/dc10-1991","article-title":"Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study","volume":"34","author":"Bae","year":"2011","journal-title":"Diabetes Care."},{"issue":"11","key":"2021122204214346300_CIT0019","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.2337\/dc07-0792","article-title":"Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men","volume":"30","author":"Shibata","year":"2007","journal-title":"Diabetes Care."},{"issue":"1","key":"2021122204214346300_CIT0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med."},{"issue":"2","key":"2021122204214346300_CIT0021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jhep.2019.04.013","article-title":"The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content","volume":"71","author":"Gepner","year":"2019","journal-title":"J Hepatol."},{"issue":"5","key":"2021122204214346300_CIT0022","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00125-010-1663-6","article-title":"The impact of liver fat vs visceral fat in determining categories of prediabetes","volume":"53","author":"Kantartzis","year":"2010","journal-title":"Diabetologia."},{"issue":"1","key":"2021122204214346300_CIT0023","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00125-013-3066-y","article-title":"Characterising metabolically healthy obesity in weight-discordant monozygotic twins","volume":"57","author":"Naukkarinen","year":"2014","journal-title":"Diabetologia."},{"issue":"8","key":"2021122204214346300_CIT0024","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/oby.2010.90","article-title":"Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction","volume":"18","author":"Magkos","year":"2010","journal-title":"Obesity (Silver Spring)."},{"issue":"15","key":"2021122204214346300_CIT0025","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med."},{"issue":"12","key":"2021122204214346300_CIT0026","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00125-017-4407-z","article-title":"Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study","volume":"60","author":"Schmid","year":"2017","journal-title":"Diabetologia."},{"issue":"5","key":"2021122204214346300_CIT0027","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2337\/dc17-2138","article-title":"The productivity burden of diabetes at a population level","volume":"41","author":"Magliano","year":"2018","journal-title":"Diabetes Care."},{"issue":"5","key":"2021122204214346300_CIT0028","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc15-0991","article-title":"An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes","volume":"39","author":"Al-Saeed","year":"2016","journal-title":"Diabetes Care."},{"issue":"4","key":"2021122204214346300_CIT0029","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/dc15-1876","article-title":"Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes","volume":"39","author":"Lomonaco","year":"2016","journal-title":"Diabetes Care."},{"issue":"12","key":"2021122204214346300_CIT0030","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes."},{"issue":"5","key":"2021122204214346300_CIT0031","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care."},{"issue":"7","key":"2021122204214346300_CIT0032","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","article-title":"Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study","volume":"105","author":"Adams","year":"2010","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2021122204214346300_CIT0033","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology."},{"issue":"5","key":"2021122204214346300_CIT0034","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology."},{"issue":"1","key":"2021122204214346300_CIT0035","first-page":"e312","article-title":"Economic and clinical burden of non-alcoholic steatohepatitis in patients with type II diabetes in the United States","volume":"70","author":"Younossi","year":"2019","journal-title":"Diabetes Care."},{"key":"2021122204214346300_CIT0036","author":"OECD","year":"2020"},{"issue":"1","key":"2021122204214346300_CIT0037","first-page":"33","article-title":"Cigarette smoking and educational level among young Israelis upon release from military service in 1988\u2013a public health challenge","volume":"28","author":"Kark","year":"1992","journal-title":"Isr J Med Sci."},{"issue":"7303","key":"2021122204214346300_CIT0038","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature09103","article-title":"The genome-wide structure of the Jewish people","volume":"466","author":"Behar","year":"2010","journal-title":"Nature."},{"issue":"2","key":"2021122204214346300_CIT0039","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/dc19-0351","article-title":"Effects of exercise in addition to a family-based lifestyle intervention program on hepatic fat in children with overweight","volume":"43","author":"Labayen","year":"2020","journal-title":"Diabetes Care."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa753\/33948539\/dgaa753.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/1\/e34\/41847147\/dgaa753.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/1\/e34\/41847147\/dgaa753.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T04:22:10Z","timestamp":1640146930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/1\/e34\/5930840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,19]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa753","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,10,19]]}}}